Supplemental Figure 2. The effect of smoking on TFF1 and TFF3 expression
The TFF1 and TFF3 expression levels were compared between smokers and non-smokers in control (Suppl. fig 2A) and CRSwNP (Suppl. fig. 2B ) group of patients. The data are presented as fold-change in subgroup of smokers relatively to the subgroup non-smokers. mRNA levels were compared using REST software (Qiagen), data are presented as Mean and Standard. Error, and p<0.05 was considered significant. 3 . The effect of allergy on TFF1 and TFF3 Expression in a) nasal polyps (NP), b) middle nasal turbinate (MNT-0), c) bulla ethmoidalis (BE) and d) control samples of middle nasal turbinate taken after 6 months (MNT-6) from CRSwNP patients. The data are presented as foldchange in subgroup of patients diagnosed with allergy relatively to the subgroup of patients without allergy. mRNA levels were compared using REST software (Qiagen), data are presented using Whisker box (Median, Standard. Error, Range), and p<0.05 was considered significant. CRSwNP -Chronic Rhinosinusitis with nasal polyps. NP-nasal polyp, MNT-0 -middle nasal turbinate at the time of FESS, BE -bulla ethmoidalis, MNT-6 -control samples of middle nasal turbinate collected six months after FESS from CRSwNP patients. Accordingly, conservative therapy of CRSwNP preceded surgical treatment. During a 6-months period patients were advised to use intranasal steroid therapy, and in some cases additionally instructed to use antibiotics. Furthermore, all patients were uniformly using local (mometasone furoate) and systemic steroids (15, 10, 5 mg oral prednisone) during a period of 3 weeks before surgical treatment.. Indication for performing FESS on CRSwNP patients was unsatisfactory response to intranasal corticosteroid sprays and antibiotics during a six-month period with persistent symptoms and reduced quality of life, while indication for septoplasty was insufficient nasal respiration. Following FESS surgery CRSwNP patients continued to use local intranasal steroids for a minimum of six months Tissue specimens for the qPCR and immunohistochemical analysis were harvested during the surgery by the same investigator and processed in the same fashion. An additional control sample was taken from CRSwNP patients 6 months after the surgery. 
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